prednisone
Showing 1 - 25 of 945
Hepatocellular Carcinoma Trial (Prednisone)
Not yet recruiting
- Hepatocellular Carcinoma
- Prednisone
- (no location specified)
Jun 2, 2023
Acute Heart Failure Trial (Prednisone)
Not yet recruiting
- Acute Heart Failure
- Prednisone
- (no location specified)
Jun 14, 2023
Nephrotic Syndrome in Children Trial (Huaiqihuang granule, Prednisone, Levamisole )
Not yet recruiting
- Nephrotic Syndrome in Children
- Huaiqihuang granule
- +4 more
- (no location specified)
Mar 6, 2023
In-stent Restenosis Trial in Beijing (Colchicine, Prednisone, Aspirin)
Not yet recruiting
- In-stent Restenosis
- Colchicine
- +4 more
-
Beijing, Beijing, ChinaFuwai Hospital
Oct 15, 2023
Facial Swelling, Tooth Position Anomalies, Tooth, Impacted Trial in Catanzaro (Prednisone, Placebo)
Completed
- Facial Swelling
- +4 more
- Prednisone
- Placebo
-
Catanzaro, CZ, ItalyMagna Graecia University of Catanzaro
Apr 23, 2023
Large B-Cell Lymphoma Trial in Xi'an (Glofitamab, Polatuzumab vedotin, Rituximab)
Not yet recruiting
- Large B-Cell Lymphoma
- Glofitamab
- +5 more
-
Xi'an, ChinaFirst Affiliated Hospital of Medical College of Xi'an Jiaotong U
Sep 14, 2023
Multiple Myeloma Trial in Saint Louis (Isatuximab, Bendamustine, Prednisone)
Recruiting
- Multiple Myeloma
- Isatuximab
- +2 more
-
Saint Louis, MissouriWashington University School of Medicine
Sep 21, 2022
Vasectomy Reversal Trial in Orem (Prednisone)
Recruiting
- Vasectomy Reversal
- Prednisone
-
Orem, UtahCure PD
Jul 19, 2022
Lymphoma, Non-Hodgkin Lymphoma, NHL Trial run by the National Cancer Institute (NCI) (Vysis LSI MYC Break Apart Rearrangement
Recruiting
- Lymphoma
- +4 more
- Vysis LSI MYC Break Apart Rearrangement Probe Kit
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Langerhans Cell Histiocytosis of Bone Trial in Shanghai (Prednisone)
Recruiting
- Langerhans Cell Histiocytosis of Bone
- Prednisone
-
Shanghai, Shanghai, ChinaShanghai Changzheng Hospital
Oct 15, 2023
Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in
Not yet recruiting
- Castration-Resistant Prostate Carcinoma
- +2 more
- Abiraterone Acetate/Niraparib
- +5 more
-
Scottsdale, ArizonaMayo Clinic in Arizona
Jan 9, 2023
Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III Merkel Cell Carcinoma AJCC v8, Clinical Stage IV Cutaneous
Not yet recruiting
- Clinical Stage III Cutaneous Melanoma AJCC v8
- +12 more
- Biopsy
- +8 more
- (no location specified)
Jun 8, 2023
Healthy, Atopic Dermatitis Trial in Daytona Beach (LY3872386, Prednisone, Placebo)
Not yet recruiting
- Healthy
- Atopic Dermatitis
- LY3872386
- +2 more
-
Daytona Beach, FloridaFortrea Clinical Research Unit
Nov 1, 2023
Immune Thrombocytopenia Trial in Beijing (Prednisone, Recombinant Human TPO)
Recruiting
- Immune Thrombocytopenia
- Prednisone
- Recombinant Human TPO
-
Beijing, ChinaPeking University Insititute of Hematology, Peking University Pe
Apr 17, 2022
Prostate Adenocarcinoma, Recurrent Prostate Carcinoma Trial in Houston (Abiraterone Acetate, Bicalutamide, Degarelix)
Active, not recruiting
- Prostate Adenocarcinoma
- Recurrent Prostate Carcinoma
- Abiraterone Acetate
- +7 more
-
Houston, TexasM D Anderson Cancer Center
Dec 5, 2022
Gout, Chronic Kidney Disease, Renal Transplantation Trial in Paris (Anakinra 100Mg/0.67Ml Inj Syringe, Prednisone, Placebo of
Recruiting
- Gout
- +2 more
- Anakinra 100Mg/0.67Ml Inj Syringe
- +3 more
-
Paris, Ile-De-France, FranceRhumathology department
Aug 22, 2022
Cutaneous Squamous Cell Carcinoma, Advanced Cancer Trial in Boston (Cemiplimab, Everolimus, Sirolimus)
Recruiting
- Cutaneous Squamous Cell Carcinoma
- Advanced Cancer
- Cemiplimab
- +3 more
-
Boston, MassachusettsDana Farber Cancer Institute
Jan 19, 2023
Metastatic Prostate Carcinoma, Prostate Adenocarcinoma, Prostate Carcinoma Metastatic in the Bone Trial in Houston (Abiraterone
Active, not recruiting
- Metastatic Prostate Carcinoma
- +5 more
- Abiraterone Acetate
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Aug 26, 2022
Prostate Cancer Trial in United States (Docetaxel-PNP, Ribociclib, Prednisone)
Prostate Cancer Metastatic, Prostate Cancer Trial in Houston (Abiraterone Acetate, Prednisone)
Recruiting
- Prostate Cancer Metastatic
- Prostate Cancer
- Abiraterone Acetate
- Prednisone
-
Houston, Texas
- +2 more
Oct 7, 2022
Lymphoma, Non-Hodgkin Lymphoma, DLBCL Trial run by the National Cancer Institute (NCI) (Venetoclax, Ibrutinib, Prednisone)
Recruiting
- Lymphoma
- +3 more
- Venetoclax
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 20, 2022
B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Recurrent B Acute
Recruiting
- B Acute Lymphoblastic Leukemia
- +2 more
- Dasatinib
- +4 more
-
Portland, OregonOHSU Knight Cancer Institute
Dec 16, 2022
Lymphoma, Non-Hodgkin Lymphoma, DLBCL Trial run by the NCI (obinutuzumab, prednisone, Revlimid)
Recruiting
- Lymphoma
- +3 more
- obinutuzumab
- +5 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jul 6, 2022
Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma Without Neuroendocrine Differentiation, Stage IV Prostate
Suspended
- Castration-Resistant Prostate Carcinoma
- +4 more
- Abiraterone Acetate
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Apr 27, 2022